| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910810223003321 |
|
|
Autore |
Taylor David <1963-, > |
|
|
Titolo |
The Maudsley prescribing guidelines in psychiatry / / David Taylor, Carol Paton, Shitij Kapur |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Chichester, West Sussex, : John Wiley & Sons, 2012 |
|
|
|
|
|
|
|
ISBN |
|
1-118-32325-4 |
0-470-97968-2 |
1-283-49701-8 |
9786613497017 |
0-470-97969-0 |
|
|
|
|
|
|
|
|
Edizione |
[11th edition.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (682 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
PatonCarol |
KapurShitij |
TaylorDavid <1946-> |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Psychopharmacology - Great Britain |
Psychotropic drugs - Great Britain |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Rev. ed. of: Prescribing guidelines. 2009. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
The Maudsley Prescribing Guidelines in Psychiatry; Contents; Preface; Acknowledgements; Notes on using The Maudsley Prescribing Guidelines; Notes on inclusion of drugs; List of abbreviations; Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants; Interpreting sample results; Chapter 2 Schizophrenia; Antipsychotic drugs; Antipsychotic drugs: equivalent doses; Antipsychotic drugs: minimum effective doses; Antipsychotic drugs: licensed maximum doses; New antipsychotic drugs; Antipsychotic drugs: general principles of prescribing |
National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia Treatment algorithms for schizophrenia; Antipsychotic drugs: monitoring of metabolic effects; Switching antipsychotic drugs because of poor tolerability; Antipsychotic response: to increase the dose, to switch, to add or just wait - what is the right move?; Speed and onset of antipsychotic drug action; First-generation antipsychotic drugs: place in therapy; Antipsychotic drugs: |
|
|
|
|
|
|
|
|
|
|
|
long-acting injections; Risperidone long-acting injection; Paliperidone palmitate long-acting injection |
Management of patients on long-term depots: dose reduction Combined antipsychotic drugs; High-dose antipsychotic drugs: prescribing and monitoring; Negative symptoms in schizophrenia; Antipsychotic prophylaxis; Refractory schizophrenia and clozapine; Clozapine augmentation; Refractory schizophrenia: alternatives to clozapine; Clozapine: management of common adverse effects; Clozapine: uncommon or unusual adverse effects; Clozapine: serious haematological and cardiovascular adverse effects; Clozapine, neutropenia and lithium; Clozapine and chemotherapy; Clozapine-related hypersalivation |
Guidelines for the initiation of clozapine for patients based in the community Omega-3 fatty acids (fish oils) in schizophrenia; Extrapyramidal side-effects of antipsychotic drug treatment; Treatment of antipsychotic-induced akathisia; Treatment of tardive dyskinesia; Neuroleptic malignant syndrome; Catatonia; Cardiovascular effects of antipsychotic drug treatment; Antipsychotic drugs and hypertension; Hyperprolactinaemia; Antipsychotic-induced weight gain; Treatment of drug-induced weight gain; Antipsychotic drugs, diabetes and impaired glucose tolerance; Antipsychotic drugs and dyslipidaemia |
Antipsychotic drugs and sexual dysfunction Antipsychotic-associated hyponatraemia; Antipsychotics and pneumonia; Relative adverse effects of antipsychotic drugs: a rough guide; Chapter 3 Bipolar disorder; Valproate; Lithium; Carbamazepine; Physical monitoring of people with bipolar disorder; Treatment of acute mania or hypomania; Antipsychotic drugs in bipolar disorder; Bipolar depression; Rapid cycling bipolar disorder; Prophylaxis in bipolar disorder; Chapter 4 Depression and anxiety; Depression; Antidepressants; Treatment of resistant depression; Treatment of psychotic depression |
Electroconvulsive therapy and psychotropic drugs |
|
|
|
|
|
|
Sommario/riassunto |
|
"Helps with complex prescribing needs.The evidence base for drug treatments in psychiatry ranges from meta-analyses and randomised controlled clinical trials to single case reports, and from NICE guidelines to individual SPCs. Where do you look for information when transferring a patient from one drug to another? Where do you find a clear overview when dealing with a complex patient (e.g, with co-morbid epilepsy or liver disease or HIV infection)? Where can you seek advice on prescribing psychotropics during pregnancy? The Maudsley Prescribing Guidelines in Psychiatry! The leading clinical reference for handling prescribing problems as encountered in daily practice and for formulating prescribing policy. Evidence-based and written by expertsThis book is the essential guide for anyone responsible for prescribing, dispensing or administering drugs for patients with mental health disorders. All the evidence has been reviewed and summarized succinctly by an expert team of psychiatrists and pharmacists. New content and improved format this new edition makes greater use of tables and boxes to facilitate quick reference and includes new sections on cytochrome-mediated interactions and psychiatric side effects of non-psychotropic drugs.Clinically relevant chapters address plasma monitoring, schizophrenia, bipolar disorder, depression and anxiety, children and adolescents, substance abuse and special patient groups. Each section has a full reference list. The book covers prescribing drugs outside their licensed indications and their interaction with substances such as alcohol, nicotine and caffeine. Useful for all levels of experience trainees will gain important information regarding the rational, safe and effective use of medications for patients with mental illness. Experienced clinicians will find excellent guidance regarding |
|
|
|
|
|
|
|
|
|
|
more complex issues that they may not encounter regularly. Why the Maudsley Prescribing Guidelines in Psychiatry? Long recognized as an international trailblazer in mental health care, the Maudsley Hospital earned its reputation for excellence in both in-patient and community care. It is highly regarded for its research, and pioneered the use of clinical neuroscience. You can trust The Maudsley Prescribing Guidelines in Psychiatry to be scientifically sound and clinically effective"--Provided by publisher. |
|
|
|
|
|
| |